Zoetis (ZTS) Current Deferred Tax Assets (2012 - 2015)
Zoetis' (ZTS) quarterly Current Deferred Tax Assets came in at $127.0 million in Q3 2015, up 19.81% year-on-year from $106.0 million in Q3 2014, and little changed on a QoQ basis from $127.0 million in Q2 2015.
Zoetis (ZTS) Current Deferred Tax Assets (2012 - 2015) Analysis & Trends
Zoetis (ZTS) has 4 years of Current Deferred Tax Assets data on file, last reported at $127.0 million in Q3 2015.
- On a quarterly basis, Current Deferred Tax Assets rose 19.81% year-over-year to $127.0 million in Q3 2015; TTM through Sep 2015 was $127.0 million, a 19.81% increase from a year earlier, with the FY2014 full-year figure at $109.0 million, up 12.37% from the prior year.
- Current Deferred Tax Assets for Q3 2015 stood at $127.0 million, roughly flat from $127.0 million in the prior quarter.
- Over the last five years, Current Deferred Tax Assets for ZTS reached as high as $127.0 million in Q2 2015 and fell as low as $66.0 million in Q3 2013.
- Historically, Current Deferred Tax Assets has averaged $99.8 million across 4 years, with a median of $99.0 million in 2012.
- Across the five-year window, Current Deferred Tax Assets surged 60.61% in 2014 and dropped 8.42% in 2015, its largest moves.
- Year by year, Current Deferred Tax Assets stood at $101.0 million in 2012, then decreased by 3.96% to $97.0 million in 2013, then climbed by 12.37% to $109.0 million in 2014, then increased by 16.51% to $127.0 million in 2015.
- Per Business Quant data, the three most recent Current Deferred Tax Assets figures were $127.0 million in Q3 2015, $127.0 million in Q2 2015, and $87.0 million in Q1 2015.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Vireo Growth | 10.57 Bn | 10.41 Bn | 59.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 27, 2015 | 127.00 Mn |
| Sep 27, 2015 | 127.00 Mn |
| Jun 28, 2015 | 127.00 Mn |
| Jun 28, 2015 | 127.00 Mn |
| Mar 29, 2015 | 87.00 Mn |
| Mar 29, 2015 | 87.00 Mn |
| Dec 31, 2014 | 109.00 Mn |
| Dec 31, 2014 | 109.00 Mn |
| Sep 28, 2014 | 106.00 Mn |
| Sep 28, 2014 | 106.00 Mn |
| Jun 29, 2014 | 108.00 Mn |
| Jun 29, 2014 | 108.00 Mn |
| Mar 30, 2014 | 95.00 Mn |
| Mar 30, 2014 | 95.00 Mn |
| Dec 31, 2013 | 97.00 Mn |
| Dec 31, 2013 | 97.00 Mn |
| Sep 29, 2013 | 66.00 Mn |
| Sep 29, 2013 | 66.00 Mn |
| Jun 30, 2013 | 92.00 Mn |
| Jun 30, 2013 | 92.00 Mn |